ImmunoGen, Inc. (IMGN) Social Stream
IMMUNOGEN INC (IMGN) Price Targets From Analysts
Use the tables below to see what analysts covering IMMUNOGEN INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 7 | $12 | $5 | $7.9 | $3.93 | 101.02% |
| 2021-12-01 | 7 | $12 | $5 | $8.9 | $3.93 | 126.46% |
| 2022-02-02 | 7 | $12 | $6.5 | $9.3 | $3.93 | 136.64% |
| 2022-02-11 | 8 | $18 | $6.5 | $10.75 | $3.93 | 173.54% |
| 2022-03-09 | 8 | $18 | $5 | $10.416 | $3.93 | 165.04% |
| 2022-03-20 | 9 | $18 | $5 | $10.416 | $3.93 | 165.04% |
| 2022-03-21 | 9 | $18 | $5 | $9.642 | $3.93 | 145.34% |
| 2022-05-06 | 9 | $18 | $5 | $9.571 | $3.93 | 143.54% |
| 2022-08-01 | 9 | $18 | $4 | $9.666 | $3.93 | 145.95% |
| 2022-08-10 | 9 | $18 | $4 | $9.428 | $3.93 | 139.9% |
| 2022-08-31 | 9 | $18 | $4 | $9.285 | $3.93 | 136.26% |
| 2022-09-09 | 9 | $18 | $4 | $9.125 | $3.93 | 132.19% |
| 2022-11-07 | 10 | $18 | $4 | $9.125 | $3.93 | 132.19% |
| 2022-11-15 | 10 | $18 | $4 | $9.25 | $3.93 | 135.37% |
| 2022-11-16 | 11 | $20 | $4 | $11 | $3.93 | 179.9% |
| 2022-11-28 | 12 | $20 | $4 | $10.9 | $3.93 | 177.35% |
| 2023-01-05 | 12 | $19.001 | $4 | $10.4 | $3.93 | 164.63% |
| 2023-02-27 | 12 | $19.001 | $4 | $10.5 | $3.93 | 167.18% |
| 2023-03-02 | 12 | $19.001 | $3 | $10.4 | $3.93 | 164.63% |
The Trend in the Analyst Price Target
Over the past 43 weeks, IMGN's average price target has gone up $0.97.
Over the past 49 weeks, IMGN's average upside potential has been 105.61%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-10 | 9 | 18 | 4 | 9.428 | 3.97 | 137.48% |
| 2022-08-01 | 9 | 18 | 4 | 9.428 | 4.53 | 108.12% |
| 2022-08-10 | 9 | 18 | 4 | 9.428 | 5.31 | 77.55% |
| 2022-09-09 | 9 | 18 | 4 | 9.125 | 5.46 | 67.12% |
| 2022-11-15 | 11 | 18 | 4 | 9.250 | 5.01 | 84.63% |
IMGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 8 | 0 | 4 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 120 days, IMGN's average broker recommendation rating improved by 0.06.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMGN as an investment opportunity.
- IMMUNOGEN INC's variance in analysts' estimates is lower than -1808.25% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, IMMUNOGEN INC's average analyst price target is higher than 215.05% of them.
- In terms of how IMMUNOGEN INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1989.9% of that group.
- In terms of how IMMUNOGEN INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 924.86% of that group.
In the Pharmaceutical Products industry, LFVN, GOVX, and XOMA are the three stocks most similar to IMMUNOGEN INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for IMGN? Use POWR Ratings for clearer insight into price direction.